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Introduction
============

The design and synthesis of new efficient pharmaceutical drugs for the treatment and prevention of a wide range of neurodegenerative diseases, such as Alzheimer's dementia, Parkinsonism and the amyotrophic lateral sclerosis, is of considerable interest in modern medicinal chemistry. Mitochondrial dysfunction was found to play a crucial role in the pathogenesis of these diseases \[[@R1]--[@R3]\]. Thus, one of the specific symptoms of such pathologies is a decrease in the ability of mitochondria to regulate the calcium homeostasis in cells and malfunction of mitochondrial permeability transition (MPT) that represents a key step in the cascades of cell death. From this point of view, mitochondria and the MPT process are very attractive targets for the search of new neuroprotective agents \[[@R4]--[@R5]\].

Several promising mitochondria-targeting neuroprotectors have been reported in the literature. Thus, the antihistaminic drug dimebon \[[@R6]--[@R7]\], which relates to tetrahydro-γ-carboline derivatives, has been found to stabilize and improve mitochondrial functions in different in vivo and in vitro models \[[@R8]--[@R9]\] ([Fig. 1](#F1){ref-type="fig"}). Another promising class of neuroprotectors are cell-permeable mitochondria-targeting synthetic small peptides, for example, the SS (Szeto--Schiller) peptide antioxidants \[[@R10]\] ([Fig. 1](#F1){ref-type="fig"}). These peptides were found to scavenge hydrogen peroxide and peroxynitrite and inhibit lipid peroxidation in vitro. By reducing mitochondrial reactive oxygen species, they inhibit MPT and cytochrome c release, thus protecting cells from oxidative cell death \[[@R11]\].

![Structures of dimebon and SS peptides.](Beilstein_J_Org_Chem-10-155-g002){#F1}

We expected that the conjugation of tetrahydro-γ-carbolines with synthetic peptides could lead to a new class of promising neuroprotectors affecting brain mitochondria. Thus, we synthesized N-substituted tetrahydro-γ-carbolines and their peptide conjugates and investigated the action of the obtained compounds on the mitochondria membrane potential, mitochondrial permeability transition and lipid peroxidation.

Results and Discussion
======================

The starting N-substituted tetrahydro-γ-carbolines **3a--d** containing a terminal alkyne group were prepared in good yields by heating compounds **1a--d** \[[@R12]--[@R13]\] with propargyl acrylate (**2**) in the presence of catalytic amounts of CsF ([Scheme 1](#C1){ref-type="fig"}).

![Synthesis of starting N-substituted tetrahydro-γ-carbolines **3a--d**.](Beilstein_J_Org_Chem-10-155-g003){#C1}

The corresponding protected azidopeptides **5** \[[@R14]--[@R15]\] are accessible by the Ugi multicomponent reaction \[[@R16]--[@R19]\] of chiral isocyanoazides **4** \[[@R20]\] with carbonyl compounds, amines and Boc-protected amino acids ([Scheme 2](#C2){ref-type="fig"}). As we showed before, the racemization of the chiral centre of the isocyanoazide does not occur under the conditions of the Ugi reaction \[[@R20]\]. This approach permits to prepare a broad variety of azidopeptides using multicomponent methodology.

![Synthesis of peptides **5** through the Ugi reaction.](Beilstein_J_Org_Chem-10-155-g004){#C2}

The modification of N-substituted tetrahydro-γ-carbolines **3a--d** by peptide fragments was performed using Cu(I)-catalyzed click chemistry -- one of the most effective conjugation methods \[[@R21]--[@R22]\]. Thus, heating the educts with Cu(II)/sodium ascorbate in a biphasic mixture of CH~2~Cl~2~/H~2~O during 1 h provided compounds **6a--g** ([Scheme 3](#C3){ref-type="fig"}). According to the ^13^C NMR spectra, the click reaction proceeds regioselective in all cases affording the desired conjugates **6a--g** in good yields.

![Synthesis of N-substituted tetrahydro-γ-carbolines containing protected peptide residues.](Beilstein_J_Org_Chem-10-155-g005){#C3}

Next, we turned our attention to the deprotection of the amine function in the peptide residues, in order to obtain water-soluble conjugates. Thus, *N*-Boc protecting groups were removed from compounds **6a--g** with 2 M HCl in methanol to give the corresponding dihydrochloride salts **7a--g** in nearly quantitative yields ([Scheme 4](#C4){ref-type="fig"}).

![Synthesis of dihydrochloride salts **7a--g**.](Beilstein_J_Org_Chem-10-155-g006){#C4}

The final dihydrochloride salts **7a--g** were tested on rat liver mitochondria (RLM) using standards tests: lipid peroxidation (LP), mitochondrial membrane potential (ΔΨ~m~) and Ca^2+^-induced mitochondrial permeability transition (MPT).

On the day of the experiment, adult male Wistar rats fasted overnight were euthanized in a CO~2~ chamber followed by decapitation. The procedure is in compliance with the Guidelines for Animal Experiments at IPAC RAS. Rat liver mitochondria were isolated by conventional differential centrifugation as previously described \[[@R23]\]. All experiments were provided with mitochondria energized by succinate in the presence of rotenone.

The influence of compounds on spontaneous or induced by *tert*-butylhydroperoxide (*t*-BHP) LP was studied by the standard assay \[[@R24]\]. The extent of LP was measured spectrophotometrically (λ~max~ = 532 nm) and malondialdehyde--thiobarbituric acid adduct concentrations (MDA, expressed in nmol/mg protein) were obtained by interpolation with a MDA standard curve from commercially available 1,1,3,3-tetramethoxypropane. All experiments were repeated using three different preparations of isolated rat liver mitochondria.

Mitochondrial membrane potential was monitored using safranine O \[[@R23]\]. The ability of the compounds to affect MPT was assessed by monitoring mitochondria swelling caused by calcium chloride addition in a plate reader (Victor3, Perkin Elmer). Swelling rate (*V* ~max~) was calculated as a slope of the steepest portion of the plot of swelling (light scattering) versus time (dA~530~ × 1000 × min^−1^).

N-substituted tetrahydro-γ-carbolines **3a--d** possessed a pro-oxidant activity. These compounds potentiated the *t*-BHP-induced LP and also induced LP of liver mitochondria. Their peptide conjugates not only lost pro-oxidant activity but, moreover, some of these compounds could inhibit both mitochondrial lipid auto-oxidation and the *t*-BHP-induced LP ([Table 1](#T1){ref-type="table"}).

###### 

The influence of N-substituted tetrahydro-γ-carbolines and their peptide conjugates on LP of rat liver mitochondria.

  -------------- ------------------------------------------------------------ --------------------------------------------------------------------------------
  Compound       LP in the presence of 0.1 mM compound, nmol MDA/mg protein   Influence of 0.1 mM compound on 1.6 mM *t*-BHP-induced LP, nmol MDA/mg protein
                                                                              
  no compounds   0.48 ± 0.01                                                  0.91 ± 0.02
  **3a**         1.72 ± 0.05                                                  7.63 ± 0.05
  **3b**         1.96 ± 0.04                                                  6.09 ± 0.08
  **3c**         1.72 ± 0.08                                                  6.05 ± 0.16
  **3d**         1.81 ± 0.08                                                  7.64 ± 0.09
  **7a**         0.39 ± 0.02                                                  0.86 ± 0.04
  **7b**         0.41 ± 0.02                                                  0.87 ± 0.06
  **7c**         0.39 ± 0.02                                                  0.79 ± 0.01
  **7d**         0.38 ± 0.02                                                  0.81 ± 0.02
  **7e**         0.4 ± 0.03                                                   0.92 ± 0.04
  **7f**         0.37 ± 0.01                                                  0.75 ± 0.02
  **7g**         0.62 ± 0.02                                                  0.95 ± 0.05
  -------------- ------------------------------------------------------------ --------------------------------------------------------------------------------

At the concentration of 100 µM (200 nmol/mg mitochondria) the studied compounds caused a week decrease of ΔΨ~m~ and demonstrated no significant influence on mitochondrial swelling (data not shown). But at higher pharmacologically relevant concentration of 30 µM (60 nmol/mg mitochondria) all compounds did not affect the ΔΨ~m~ and increased the resistance of mitochondria to calcium-induced MPT ([Table 2](#T2){ref-type="table"}). The results of biological evaluation revealed an antioxidant and mitoprotective potential of the new synthesized peptide-modified N-substituted tetrahydro-γ-carbolines. Further investigations of this class of compounds may allow finding a promising approach to cytoprotection, in particularly, neuroprotection.

###### 

The influence of the peptide conjugates of N-substituted tetrahydro-γ-carbolines on rat liver mitochondria swelling.^a^

  ----------- --------------------------
  Compounds   ΔA530/min (% of control)
              
  **7a**      70.5 ± 4.6
  **7b**      79.9 ± 8.1
  **7c**      80.9 ± 8.0
  **7d**      76.2 ± 7.5
  **7e**      72.4 ± 2.7
  **7f**      70.2 ± 8.6
  **7g**      79.0 ± 6.7
  ----------- --------------------------

^a^Quantification of swelling was measured as the maximal velocity of A530 change after CaCl~2~ addition. The values were normalized against the control values, set to 100%. Data are expressed as means ± SD (*n* = 3 or 4).

Conclusion
==========

In summary, we described the conjugation of N-substituted tetrahydro-γ-carbolines containing a terminal alkyne group **3a--d** with various azidopeptides **5** (prepared by Ugi multicomponent reaction) through the Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition. The activity of the obtained compounds on rat liver mitochondria functional characteristics, such as mitochondrial transmembrane potential, calcium-induced mitochondrial permeability transition and lipid peroxidation of mitochondrial membrane was evaluated. It was found that all compounds at a concentration of 30 µM did not induce depolarization of mitochondria but possessed some inhibitory effect on the mitochondria permeability transition. The starting N-substituted tetrahydro-γ-carbolines **3a--d** demonstrated a high pro-oxidant activity, whereas their peptide conjugates inhibited both auto-oxidation and the *t*-BHP-induced lipid peroxidation.

Experimental
============

General Information
-------------------

^1^H and ^13^C NMR spectra were recorded in deuterated solvents on a Bruker Avance 400 MHz spectrometer. ^19^F NMR spectra were recorded on a Bruker DXP 200 MHz spectrometer. ^1^H and ^13^C chemical shifts are reported in parts per million (ppm) or δ values downfield from TMS as internal standard. Deuterated solvent peaks were used as internal references: CDCl~3~ at 7.25 and 77.00 ppm. ^19^F chemical shifts are reported on δ scale (in ppm) downfield from CF~3~COOH. Liquid chromatography was performed using Fluka silica gel 60 (0.063--0.200 mm). Melting points were determined with an Electrothermal IA9100 Digital Melting Point Apparatus and are uncorrected. Optical rotations were measured on a Perkin-Elmer 341 polarimeter at 589 nm. High-resolution mass spectra (HRMS) were measured on a MicrOTOF II (Bruker Daltonics) spectrometer.

Compounds **1a--d** were obtained from the respective arylhydrazine hydrochlorides and N-substituted 4-piperidones using Fischer indole synthesis \[[@R12]--[@R13]\]. Propargyl acrylate (**2**) was obtained from propargyl alcohol and acryloyl chloride according to procedure described in \[[@R25]\].

**General procedure for the synthesis of compounds 3a--d:** A mixture of correspondingly substituted 2,3,4,5-tetrahydro-1*H*-pyrido\[4,3-*b*\]indole **1a--d** (2 mmol), 0.22 g (2 mmol) acrylic acid propyn-2-yl ester (**2**) and 0.1 g (0.66 mmol) of CsF in 1 mL of DMF was stirred at 110 °C during 2 h. The solvent was removed in vacuo (\~3 mmHg) and the product was extracted from the residue with CH~2~Cl~2~. The solvent was removed in vacuo and the residue was purified by column chromatography (MeOH/CHCl~3~ 1:5).

**General procedure for the Ugi-4CC synthesis of peptides 5:** As described in \[[@R14]\], the corresponding amine (1 mmol) and acetone or CH~2~O (40% in H~2~O, 1 mmol) were dissolved in 5 mL of MeOH and *N*-Boc-protected amino acid (1 mmol) and isocyanide **4** (1 mmol) were added at room temperature. The mixture was stirred for 24 h. The solvent was removed in vacuo and the residue was purified by column chromatography (hexanes/ethyl acetate) to give compounds **5**.

**General procedure for the synthesis of compounds 6a--g:** To a solution of acetylene **3** (0.5 mmol) in 5 mL of CH~2~Cl~2~ was added the peptide **5** (0.5 mmol), 0.012 g (0.05 mmol) of CuSO~4~·5H~2~O in 0.25 mL of H~2~O and 0.04 g (0.2 mmol) of sodium ascorbate in 0.25 mL of H~2~O. The reaction mixture was stirred at 40 °С for 1 h. After the reaction was completed 10 mL of CH~2~Cl~2~ was added and the reaction mixture was washed with aq NH~3~ and then with water. The organic layer was separated and dried over Na~2~SO~4~. The solvent was removed in vacuo and the residue was purified by column chromatography (CH~2~Cl~2~/MeOH 10:1).

**General procedure for the synthesis of dihydrochlorides 7a--g:** The corresponding compound **6a--g** (0.12 mmol) was dissolved in 1 mL (2 mmol) of a 2 M solution of HCl in MeOH. The reaction mixture was stirred at room temperature for 2 h. The solvent was removed in vacuo and the residue was dissolved in 5 mL of EtOH. Then the solvent was evaporated and 5 mL of acetonitrile were added to the residue. After evaporation of the solvent the corresponding dihydrochlorides **7a--g** were obtained.

Supporting Information
======================

###### 

General information and characterization data for all compounds.
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